|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||0.00 - 0.00|
|52 Week Range|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
In fact, many investors often forget the stocks that trade on the Over the Counter Bulletin Board (OTCBB). Some refer to these OTC stocks to buy as equities that trade on the “pink sheets,” named for the color of the paper on which they were printed before electronic trading became more widespread. Stocks end up on the pink sheets either because they either fail to meet or have not attempted to meet the listing requirements of the New York Stock Exchange or the Nasdaq.
CORAL GABLES, FL / ACCESSWIRE / July 27, 2018 / The marijuana industry and marijuana stocks in general have been getting a lot more attention lately.Canada’s decision to legalize recreational marijuana on a national scale has jump-started the market once again.The summer however has typically been a time where pot stocks are more steady and not as aggressively volatile leading into the 3rd quarter. This year has seen some of the biggest cannabis IPO’s and this may be a trend that is far from over.Though some marijuana stocks may have consolidated, there are others that have blossomed just this week, to fresh weekly highs. Leafbuyer Technologies (LBUY) finds itself hitting early morning highs of $1.23.This is higher by nearly 11% from this week’s lows of $1.11.
The purchase secures licenses to cultivate cannabis and produce extracts in Colombia, which will feed MedReleaf’s global supply chain with low-cost, high-quality raw materials. “As the legalization of medical cannabis continues to expand, we must ensure that our ability to cultivate cost effectively extends beyond Canada to supply our global operations,” MedReleaf CEO Neil Closner said in a statement.
The deal granted MedReleaf shareholders 3.575 common shares of Aurora for each MedReleaf share held. This transaction creates a strong industry leader with the combined funded capacity of more than 570,000 kg of cannabis for annual distribution, according to Aurora.
Will Scotts Miracle-Gro's Q3 Earnings Be Another Disappointment? Scotts Miracle-Gro (SMG) has traditionally served the lawn and gardening market with the US being its biggest market. For more information, read Company Overview: The Scotts Miracle-Gro Company.
NEW YORK, NY / ACCESSWIRE / July 24, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on MedReleaf Corp. (OTC PINK: MEDFF), an R&D-driven company dedicated to innovation, operational excellence and the production of industry-leading, top-quality cannabis. On May 14, 2018, Aurora Cannabis Inc. and the Company entered into an arrangement agreement, pursuant to which Aurora will acquire all of the outstanding common shares of the Company and each shareholder of the Company will be entitled to receive 3.575 common shares of Aurora and $0.000001 in cash in exchange for each Common Share held.
The cannabis sector continued to slide last week. The benchmark Horizons Marijuana Life Sciences ETF (HMMJ) declined 9.2% between July 13 and July 20. Similarly, the Emerging Marijuana Growers Index ETF (HMJR) declined 5.6%, and the ETFMG Alternative Harvest ETF (MJ) declined by 5.5% over the same period.
NEW YORK, NY / ACCESSWIRE / July 9, 2018 / U.S. equities posted solid gains on Friday, ending the week on a positive note, supported by a stronger-than-expected jobs report. The Dow Jones Industrial Average ...
NEW YORK, NY / ACCESSWIRE / June 22, 2018 / Major U.S. markets closed down on Thursday, with the Dow Jones posting its 8th consecutive daily decline, as investors' attention remained fixed on trade tension ...
Canopy Growth Corp (NYSE:CGC), the second Canadian pure-play marijuana stock, hit U.S. markets May 24. American investors now have direct access to two of the biggest players in the global cannabis market. There are a number of different ways investors can put their hard-earned dollars to work in what is arguably one of the fastest growing industries in the world, but the easiest is to buy one of the several marijuana ETFs available.
NEW YORK, NY / ACCESSWIRE / June 6, 2018 / Major indexes closed mostly higher Tuesday, lifted by a rally from the technology sector. The Dow Jones Industrial Average decreased 0.06 percent to close at ...
EDMONTON and MARKHAM, ON , May 25, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora") (ACB.TO) and MedReleaf Corp. ("MedReleaf") (LEAF.TO) today announced the filing on SEDAR of the arrangement agreement dated May 14, 2018 between Aurora and MedReleaf (the "Original Agreement"), as amended by an amending agreement (the "Amending Agreement"), and the material change reports in respect of the previously announced transaction whereby Aurora intends to acquire all of the issued and outstanding common shares of MedReleaf (the "Material Change Reports"). Aurora and MedReleaf have agreed to amend the Original Agreement to include, in the consideration payable to holders of MedReleaf's common shares, (each a "MedReleaf Share"), $0.000001 in cash for each MedReleaf Share. As a result, the consideration under the arrangement has been increased from 3.575 Aurora common shares for each MedReleaf Share to 3.575 Aurora common shares and $0.000001 in cash for each MedReleaf Share. Taxable Canadian resident MedReleaf shareholders will be entitled to elect to receive tax-deferred roll-over treatment in connection with the acquisition by Aurora of their MedReleaf Shares. If a MedReleaf shareholder does not, or is unable to, make an election, then Aurora's acquisition cost for such shareholder's MedReleaf Shares will generally be equal to the fair market value of such shares.
On May 22, Aurora Cannabis (ACB) (ACBFF) added yet another name to its long list of partnerships ahead of legalized cannabis in Canada. The company acquired a 9.1% ownership interest in CTT Pharmaceutical Holdings through a private placement. This deal further has a provision for Aurora Cannabis to increase its stake to 42.5% in CTT.
With the anticipation of huge demand for cannabis, which translates into potential earnings growth, analysts are quite bullish on cannabis stocks in May. Most companies have seen increased bullishness over the last month, as we’ll discuss in this series. On May 15, Canopy Growth (WEED) stock was in the news again for its latest agreement to acquire Canopy Health Innovation and its subsidiary, Canopy Animal Health.
Cronos Group (CRON) reported its first-quarter earnings on May 15. The company’s sales rose almost 4.8 times year-over-year to 2.9 million Canadian dollars from 0.5 million Canadian dollars in the first quarter of 2017. Sequentially, sales grew 83% from 1.3 million Canadian dollars.
Aurora Cannabis is buying MedReleaf in the biggest marijuana acquisition ever. But here's why investors aren't overly excited.
Today, Canopy Growth (WEED) stock surged more than 7% on news of its application to list its common shares on the NYSE (New York Stock Exchange). This news comes on the heels of Aurora Cannabis (ACB)(ACBFF) announcing its acquisition of MedReleaf (MEDFF) today. Read more in MedReleaf Stock Rises on Aurora Cannabis Acquisition.
Today, Aurora Cannabis (ACB)(ACBFF) announced that it agreed to acquire all of MedReleaf’s (MEDFF) outstanding common shares for about 3.2 billion Canadian dollars. On the other hand, Aurora Cannabis stock fell almost 2.5% to 7.9 Canadian dollars. According to Aurora Cannabis’s press release, the acquisition price of 29.4 Canadian dollars implies a premium of 34% over both companies’ 20-day VWAP (volume-weighted average price) common shares as of May 11.
Aurora Cannabis on Monday agreed to buy fellow Canadian pot stock MedReleaf for $2.5 billion, a record industry deal. Canada's Canopy Growth plans a NYSE listing.
Strong sentiment in the cannabis sector pushed ETFs and stocks into positive territory last week. The Horizons Marijuana Life Sciences ETF (HMMJ) closed 4.4% higher, while its US-listed counterpart, the Horizons Marijuana Life Sciences Index ETF (HMLSF), rose 4.8%. Similarly, the Emerging Marijuana Growers Index ETF (HMJR) rose 4.3%, and the Evolve Marijuana ETD (SEED) rose 2.5% between its close on May 4 and its close on May 11.